TwinStrand Biosciences nabs $50m Series B
TwinStrand Biosciences, a developer of duplex sequencing, has closed $50 million in Series B financing.
TwinStrand Biosciences, a developer of duplex sequencing, has closed $50 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination